Skip to main content
Industry News
Financing round pulls in $20M for Rebus Biosystems
11/20/2020

Rebus Biosystems, developer of the patented synthetic aperture optics system, has raised $20 million in a Series B financing round led by Illumina Ventures.

Full Story: